Tandem Diabetes Care, Inc.
TNDM
$22.72
-$0.13-0.57%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 234.42M | 282.65M | 243.97M | 221.91M | 191.67M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 234.42M | 282.65M | 243.97M | 221.91M | 191.67M |
| Cost of Revenue | 116.02M | 125.19M | 119.32M | 109.12M | 97.00M |
| Gross Profit | 118.41M | 157.46M | 124.65M | 112.79M | 94.67M |
| SG&A Expenses | 104.97M | 105.84M | 99.64M | 94.24M | 90.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 268.92M | 283.23M | 270.06M | 252.68M | 233.35M |
| Operating Income | -34.49M | -582.00K | -26.09M | -30.77M | -41.68M |
| Income Before Tax | -122.09M | 16.00K | -22.61M | -29.74M | -39.53M |
| Income Tax Expenses | 8.47M | -739.00K | 637.00K | 1.07M | 3.19M |
| Earnings from Continuing Operations | -130.56M | 755.00K | -23.25M | -30.81M | -42.72M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -130.56M | 755.00K | -23.25M | -30.81M | -42.72M |
| EBIT | -34.49M | -582.00K | -26.09M | -30.77M | -41.68M |
| EBITDA | -30.18M | 3.66M | -21.88M | -26.67M | -37.64M |
| EPS Basic | -1.97 | 0.01 | -0.35 | -0.47 | -0.65 |
| Normalized Basic EPS | -0.34 | 0.02 | -0.22 | -0.27 | -0.37 |
| EPS Diluted | -1.97 | 0.01 | -0.35 | -0.47 | -0.65 |
| Normalized Diluted EPS | -0.34 | 0.02 | -0.22 | -0.27 | -0.37 |
| Average Basic Shares Outstanding | 66.40M | 65.94M | 65.54M | 64.99M | 65.33M |
| Average Diluted Shares Outstanding | 66.40M | 66.16M | 65.54M | 64.99M | 65.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |